Vise Technologies’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Vise Technologies's ELV Position: Q2 2026 in Review
Vise Technologies sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 8,088 shares — an estimated $2.84M sold.
Vise Technologies first reported a position in ELV in Q1 2022 and held it in 16 quarters. The position peaked at $2.84M in Q1 2026. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Vise Technologies reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Vise Technologies sold 8,088 Elevance Health shares in Q2 2026, an estimated $2.84M.
- Vise Technologies first reported a position in Elevance Health in Q1 2022 and held it in 16 quarters.
- Vise Technologies's Elevance Health position peaked at $2.84M in Q1 2026.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.